Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 23333419)

1.

Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against "rings and rods"-associated inosine-5'-monophosphate dehydrogenase 2 in viral hepatitis C.

Probst C, Radzimski C, Blöcker IM, Teegen B, Bogdanos DP, Stöcker W, Komorowski L.

Clin Chim Acta. 2013 Mar 15;418:91-6. doi: 10.1016/j.cca.2013.01.003. Epub 2013 Jan 16.

PMID:
23333419
2.

Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection.

Seelig HP, Appelhans H, Bauer O, Blüthner M, Hartung K, Schranz P, Schultze D, Seelig CA, Volkmann M.

Clin Lab. 2011;57(9-10):753-65.

PMID:
22029192
3.

Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection.

Stinton LM, Myers RP, Coffin CS, Fritzler MJ.

BMC Gastroenterol. 2013 Mar 19;13:50. doi: 10.1186/1471-230X-13-50.

4.

Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis.

Radzimski C, Probst C, Teegen B, Rentzsch K, Blöcker IM, Dähnrich C, Schlumberger W, Stöcker W, Bogdanos DP, Komorowski L.

Clin Dev Immunol. 2013;2013:572815. doi: 10.1155/2013/572815. Epub 2013 Jan 16.

5.

Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients.

Carcamo WC, Ceribelli A, Calise SJ, Krueger C, Liu C, Daves M, Villalta D, Bizzaro N, Satoh M, Chan EK.

J Clin Immunol. 2013 Feb;33(2):420-6. doi: 10.1007/s10875-012-9827-4. Epub 2012 Oct 26.

PMID:
23100146
6.

Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.

Keppeke GD, Satoh M, Ferraz ML, Chan EK, Andrade LE.

Immunol Res. 2014 Oct;60(1):38-49. doi: 10.1007/s12026-014-8515-2.

PMID:
24845459
7.

Anti-rods/rings: a human model of drug-induced autoantibody generation.

Calise SJ, Keppeke GD, Andrade LE, Chan EK.

Front Immunol. 2015 Feb 5;6:41. doi: 10.3389/fimmu.2015.00041. eCollection 2015. Review.

8.
9.

Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.

Covini G, Carcamo WC, Bredi E, von Mühlen CA, Colombo M, Chan EK.

Antivir Ther. 2012;17(5):805-11. doi: 10.3851/IMP1993. Epub 2011 Dec 1.

PMID:
22293655
10.

Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection.

Wu YY, Hsu TC, Chen TY, Liu TC, Liu GY, Lee YJ, Tsay GJ.

Clin Exp Immunol. 2002 May;128(2):347-52.

11.

Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis.

He Y, Mou Z, Li W, Liu B, Fu T, Zhao S, Xiang D, Wu Y.

Int J Colorectal Dis. 2009 Nov;24(11):1271-9. doi: 10.1007/s00384-009-0759-2. Epub 2009 Jul 14.

PMID:
19597826
12.

Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.

Dähnrich C, Komorowski L, Probst C, Seitz-Polski B, Esnault V, Wetzels JF, Hofstra JM, Hoxha E, Stahl RA, Lambeau G, Stöcker W, Schlumberger W.

Clin Chim Acta. 2013 Jun 5;421:213-8. doi: 10.1016/j.cca.2013.03.015. Epub 2013 Mar 27.

PMID:
23541686
13.

Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.

Dalekos GN, Makri E, Loges S, Obermayer-Straub P, Zachou K, Tsikrikas T, Schmidt E, Papadamou G, Manns MP.

Eur J Gastroenterol Hepatol. 2002 Jan;14(1):35-42.

PMID:
11782573
14.

Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells.

Carcamo WC, Satoh M, Kasahara H, Terada N, Hamazaki T, Chan JY, Yao B, Tamayo S, Covini G, von Mühlen CA, Chan EK.

PLoS One. 2011;6(12):e29690. doi: 10.1371/journal.pone.0029690. Epub 2011 Dec 29.

15.

Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.

Muratori L, Lenzi M, Ma Y, Cataleta M, Mieli-Vergani G, Vergani D, Bianchi FB.

Gut. 1995 Sep;37(3):406-12.

16.

Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C.

Nishioka M, Morshed SA, Kono K, Himoto T, Parveen S, Arima K, Watanabe S, Manns MP.

J Hepatol. 1997 May;26(5):992-1000.

PMID:
9186829
17.
18.
19.

Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases.

Miyakawa H, Kikazawa E, Abe K, Kikuchi K, Fujikawa H, Matsushita M, Kawaguchi N, Morizane T, Ohya K, Kako M.

Autoimmunity. 1999;30(2):107-14.

PMID:
10435724
20.

Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection.

Durazzo M, Philipp T, Van Pelt FN, Lüttig B, Borghesio E, Michel G, Schmidt E, Loges S, Rizzetto M, Manns MP.

Gastroenterology. 1995 Feb;108(2):455-62.

PMID:
7835588
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk